214
Participants
Start Date
June 1, 2025
Primary Completion Date
June 30, 2028
Study Completion Date
June 30, 2028
TGF-β2-enriched food for special medical purposes
"The experimental treatment is Modulen-IBD®, a food for special medical purpose, polymeric, enriched with TGF-beta. If the patient refuses the experimental supplementation, NGT will be proposed to ensure the correct intake of Modulen-IBD® supplementation.~If the patient refuses, not tolerates, or there are contraindications to NGT placement, best supportive therapy will be warranted as reported below (BST)."
BST
Best Nutritional Supportive Treatment as per center's policy according to EBMT Handbook 2024
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
OTHER